The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study
Open accessAbstract
Background: We assessed whether plasma troponin I measured by a high-sensitivity assay (hs-TnI) is associated with incident cardiovascular disease (CVD) and mortality in a community-based sample without prior CVD. Methods: ARIC study (Atherosclerosis Risk in Communities) participants aged 54 to 74 years without baseline CVD were included in this study (n=8121). Cox proportional hazards models were constructed to determine associations between hs-TnI and incident coronary heart disease (CHD; myocardial infarction and fatal CHD), ischemic stroke, atherosclerotic CVD (CHD and stroke), heart failure hospitalization, global CVD (atherosclerotic CVD and heart failure), and all-cause mortality. The comparative association of hs-TnI and high-sensitivity troponin T with incident CVD events was also evaluated. Risk prediction models were constructed to assess prediction improvement when hs-TnI was added to traditional risk factors used in the Pooled Cohort Equation. Results: The median follow-up period was ≈15 years. Detectable hs-TnI levels were observed in 85% of the study population. In adjusted models, in comparison to low hs-TnI (lowest quintile, hs-TnI ≤1.3 ng/L), elevated hs-TnI (highest quintile, hs-TnI ≥3.8 ng/L) was associated with greater incident CHD (hazard ratio [HR], 2.20; 95% CI, 1.64–2.95), ischemic stroke (HR, 2.99; 95% CI, 2.01–4.46), atherosclerotic CVD (HR, 2.36; 95% CI, 1.86–3.00), heart failure hospitalization (HR, 4.20; 95% CI, 3.28–5.37), global CVD (HR, 3.01; 95% CI, 2.50–3.63), and all-cause mortality (HR, 1.83; 95% CI, 1.56–2.14). hs-TnI was observed to have a stronger association with incident global CVD events in white than in black individuals and a stronger association with incident CHD in women than in men. hs-TnI and high-sensitivity troponin T were only modestly correlated ( r =0.47) and were complementary in prediction of incident CVD events, with elevation of both troponins conferring the highest risk in comparison with elevation in either one alone. The addition of hs-TnI to the Pooled Cohort Equation model improved risk prediction for atherosclerotic CVD, heart failure, and global CVD. Conclusions: Elevated hs-TnI is strongly associated with increased global CVD incidence in the general population independent of traditional risk factors. hs-TnI and high-sensitivity troponin T provide complementary rather than redundant information.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays
Apple, F. S., Collinson, P. O., & for the IFCC Task Force on Clinical Applications of Cardiac Biomarkers (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.165795 · Cited by 861
Katrukha, A. G., Bereznikova, A. V., Esakova, T. V., Pettersson, K., Lövgren, T., Severina, M. E., Pulkki, K., Vuopio-Pulkki, L.-M., & Gusev, N. B. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.8.1379 · Cited by 266
Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study
Kucharska-Newton, A. M., Couper, D. J., Pankow, J. S., Prineas, R. J., Rea, T. D., Sotoodehnia, N., Chakravarti, A., Folsom, A. R., Siscovick, D. S., & Rosamond, W. D. (2010) · Acta Diabetologica · doi:10.1007/s00592-009-0157-9 · Cited by 73
Self-citation
Cited by
Wearable chemical sensors for biomarker discovery in the omics era
Sempionatto, J. R., Lasalde-Ramírez, J. A., Mahato, K., Wang, J., & Gao, W. (2022) · Nature Reviews Chemistry · doi:10.1038/s41570-022-00439-w · Cited by 613
The ARIC (Atherosclerosis Risk In Communities) Study
Wright, J. D., Folsom, A. R., Coresh, J., Sharrett, A. R., Couper, D., Wagenknecht, L. E., Mosley, T. H., Ballantyne, C. M., Boerwinkle, E. A., Rosamond, W. D., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.035 · Cited by 552
Self-citationKontos, M. C., de Lemos, J. A., Deitelzweig, S. B., Diercks, D. B., Gore, M. O., Hess, E. P., McCarthy, C. P., McCord, J. K., Musey, P. I., Villines, T. C., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.08.750 · Cited by 260
Self-citationCanty, J. M. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00093.2022 · Cited by 67
Romero-Cabrera, J. L., Ankeny, J., Fernández-Montero, A., Kales, S. N., & Smith, D. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113540 · Cited by 63
“Additional biomarkers have also been investigated to determine their ability to predict CVD events, including cardiac biomarkers that could suggest existing cardiac damage, such as high-sensitive troponin (hsTn) [9] or N-terminal pro-brain natriuretic (NT pro-BNP) [10], and digestive biomarkers such as gamma-glutamyl…”
Background
Metadata
- Authors
- Jia, X., Sun, W., Hoogeveen, R. C., Nambi, V., Matsushita, K., Folsom, A. R., Heiss, G., Couper, D. J., Solomon, S. D., Boerwinkle, E., Shah, A., Selvin, E., de Lemos, J. A., & Ballantyne, C. M.
- Venue
- Circulation
- Published
- 2019-06-04
- Volume
- 139
- Issue
- 23
- Pages
- 2642-2653
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2940456281
- Cited by
- 223
- References
- 5
- FWCI
- 21.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study. https://app.cochat.ai/papers/10.1161/circulationaha.118.038772
- The paper
- Jia, X., Sun, W., Hoogeveen, R. C., Nambi, V., Matsushita, K., Folsom, A. R., Heiss, G., Couper, D. J., Solomon, S. D., Boerwinkle, E., Shah, A., Selvin, E., de Lemos, J. A., & Ballantyne, C. M. (2019). High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study. Circulation. https://doi.org/10.1161/circulationaha.118.038772
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.